Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience
Christoph Boss, Catherine Brisbare‐Roch, François Jenck
Journal of Medicinal Chemistry (2009) Vol. 52, Iss. 4, pp. 891-903
Closed Access | Times Cited: 71

Showing 51-75 of 71 citing articles:

Essential structure of orexin 1 receptor antagonist YNT-707, Part I: Role of the 4,5-epoxy ring for binding with orexin 1 receptor
Naoshi Yamamoto, Sayaka Ohrui, Takahiro Okada, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 17, pp. 4176-4179
Closed Access | Times Cited: 13
Orexin Receptor Antagonists
J.A. Christopher
Pharmaceutical Patent Analyst (2012) Vol. 1, Iss. 3, pp. 329-346
Closed Access | Times Cited: 13
Small-molecule Antagonists of the Orexin Receptors
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders
Scott D. Kuduk, Christopher J. Winrow, Paul J. Coleman
Annual reports in medicinal chemistry (2013), pp. 73-87
Closed Access | Times Cited: 11
Synthesis, structure–activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 7, pp. 2212-2216
Closed Access | Times Cited: 11
The Literature of Heterocyclic Chemistry, Part XI, 2008–2009
Л. И. Беленький, Yu. B. Evdokimenkova
Advances in heterocyclic chemistry (2012), pp. 195-290
Closed Access | Times Cited: 10
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability
David A. Perrey, Ann M. Decker, Yanan Zhang
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 3, pp. 587-602
Open Access | Times Cited: 10
Stereoselective total synthesis of almorexant
N. Siva Senkar Reddy, B. V. Subba Reddy
Tetrahedron Letters (2014) Vol. 55, Iss. 20, pp. 3157-3159
Closed Access | Times Cited: 10
A rhodium-catalysed three-component reaction to access C1-substituted tetrahydroisoquinolines
Dan Zhang, Junwen Liu, Zhenghui Kang, et al.
Organic & Biomolecular Chemistry (2019) Vol. 17, Iss. 46, pp. 9844-9848
Closed Access | Times Cited: 7
Production of Bioactives Compounds: The Importance of Pictet–Spengler Reaction in the XXI Century
Pilar Menéndez, Ilaria D’Acquarica, Giuliano Delle Monache, et al.
(2012), pp. 453-487
Closed Access | Times Cited: 6
A Versatile Pre and Post Ugi Modification for the Synthesis of Natural Product Inspired Fused Peptide‐Carboline Scaffolds as Potential Anti‐Leishmanial Agents
Irfan Khan, Jaybir Singh, Vivek Kumar, et al.
ChemistrySelect (2019) Vol. 4, Iss. 42, pp. 12260-12267
Closed Access | Times Cited: 6
Asymmetric synthesis of six tetrahydroisoquinoline natural products through α-amination of an aldehyde
Anas Ansari, Amol B. Gorde, Ramesh Ramapanicker
Tetrahedron (2021) Vol. 88, pp. 132121-132121
Closed Access | Times Cited: 4
Treatment and prevention of various therapeutic conditions using OX receptor antagonistic activity (WO2012081692)
J.A. Christopher, Miles Congreve
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 2, pp. 273-277
Closed Access | Times Cited: 3
Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Synthesis and biological activity evaluation of azacycloheptane sulfonamide derivatives as potential orexin receptor antagonists
Bin Guo, Jingya Xiu, Yi Shen, et al.
RSC Advances (2020) Vol. 10, Iss. 51, pp. 30683-30691
Open Access | Times Cited: 1
Orexins (Hypocretins)
Marc Laburthe, Thierry Voisin
Elsevier eBooks (2013), pp. 541-547
Closed Access
Data from Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
(2023)
Open Access
Data from Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
(2023)
Open Access
Frontiers in Medicinal Chemistry 2009—a Summary of the Meeting at Heidelberg University
Christian Gege, Christian D. Klein
ChemMedChem (2009) Vol. 4, Iss. 8, pp. 1371-1376
Closed Access
An Efficient Method for the Synthesis of N-Aryl Substituted C1-Functionalized 1,2,3,4-Tetrahydroisoquinolines
Hairong Luo, Meihang Chen, Fen Tian, et al.
Heterocycles (2022) Vol. 104, Iss. 9, pp. 1641-1641
Open Access
Previous Page - Page 3

Scroll to top